Jefferies related stories
All articles and analysis
Side Letter: PE's continuation/co-investment conundrumThe rise of continuation funds is blurring the lines between them and what might be considered a co-investment. Plus: CPP Investments has a buyer for part of its hefty private equity portfolio sale; and Blackstone has raised its latest Tac Opps fund. Here's today's brief, for our valued subscribers only.
Side Letter: PE's earnings roundup; Eaton's Credit Suisse capturesWhat we've learned about private equity from this year's H1 earnings calls. Plus: Eaton Partners has hired a former Secondaries Investor Young Gun; and CVC is said to be thinking about listing. Here's today's brief, for our valued subscribers only.
How Canada’s BCI stays liquid in an illiquid marketThe $173bn institution is offloading PE stakes via secondaries as it looks to deploy more capital into directs, global PE head Jim Pittman tells PEI.
Side Letter: KKR's wealth wave; Jefferies' Credit Suisse coupKKR's democratised private markets products are already attracting substantial capital. Plus: Jefferies is tapping a large team of former Credit Suisse fundraisers. Here's today's brief, for our valued subscribers only.
Side Letter: NAV loan dynamics; Permira's AltamarCAM acquisition; Eurazeo's highlightsWhat the higher cost of borrowing means for the NAV loan market. Plus: Permira has made an unusual entrance to the world of GP stakes; and highlights from Eurazeo's latest earnings. Here's today's brief, for our valued subscribers only.
Arctos turns to alternatives industry with new strategy launchArctos Keystone's offerings could include tailored GP stake sales, bespoke continuation funds and asset or fund-level recapitalisations, executives from the group tell PEI.
Healthcare front of mind for secondaries buyersHealthcare-related assets make up a significant chunk of potential dealflow in the GP-led secondaries market given the sector’s characteristics and outlook.
Side Letter: Brookfield's long-hold prep; EQT's €2.7bn; LPs foray into fund financeBrookfield is gearing up for its long-awaited long-hold strategy. Plus: EQT is setting records with its impact fund; and LPs are piling into fund finance. Here’s today's brief, for our valued subscribers only.
Side Letter: KKR's $8bn close; 5x continuation vindication; CalSTRS' two-pronged climate planKKR has closed its latest European flagship. Plus: How CalSTRS aims to deploy billions into climate investing; and the SEC is taking a closer look at third-party valuations. Here’s today's brief, for our valued subscribers only.
ArchiMed scores 300x return for debut fund with Polyplus exitArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €2.4bn.